Profil
Karin Eklund Vanderpol is currently Vice President-Regulatory Affairs at Vicore Pharma Holding AB since 2022.
Former positions include Director-Global Regulatory Affairs at Swedish Orphan Biovitrum AB, Head-Regulatory Affairs at AstraZeneca AB, and Head-Regulatory Affairs at Oncopeptides AB from 2020 to 2022.
Education includes a graduate degree from the University of Uppsala.
Aktiva positioner av Karin Eklund Vanderpol
| Företag | Position | Start |
|---|---|---|
| VICORE PHARMA HOLDING AB | Generell Rådgivare | 2022-01-01 |
Tidigare kända positioner av Karin Eklund Vanderpol
| Företag | Position | Slut |
|---|---|---|
| ONCOPEPTIDES AB | Generell Rådgivare | 2022-01-01 |
| SWEDISH ORPHAN BIOVITRUM AB | Generell Rådgivare | 2019-12-01 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Generell Rådgivare | - |
Karin Eklund Vanderpols utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Vicore Pharma Holding AB
Vicore Pharma Holding AB Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for lung diseases | Health Technology |
















